KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Farmland Partners (FPI) Interest Expenses (2016 - 2025)

Farmland Partners has reported Interest Expenses over the past 13 years, most recently at $2.3 million for Q4 2025.

  • Quarterly results put Interest Expenses at $2.3 million for Q4 2025, down 25.77% from a year ago — trailing twelve months through Dec 2025 was $9.6 million (down 48.94% YoY), and the annual figure for FY2025 was $9.6 million, down 48.94%.
  • Interest Expenses for Q4 2025 was $2.3 million at Farmland Partners, roughly flat from $2.3 million in the prior quarter.
  • Over the last five years, Interest Expenses for FPI hit a ceiling of $6.2 million in Q3 2023 and a floor of $2.3 million in Q3 2025.
  • Median Interest Expenses over the past 5 years was $4.0 million (2021), compared with a mean of $4.2 million.
  • Biggest five-year swings in Interest Expenses: surged 60.11% in 2023 and later tumbled 58.68% in 2025.
  • Farmland Partners' Interest Expenses stood at $4.0 million in 2021, then grew by 18.38% to $4.7 million in 2022, then rose by 20.87% to $5.7 million in 2023, then crashed by 45.7% to $3.1 million in 2024, then dropped by 25.77% to $2.3 million in 2025.
  • The last three reported values for Interest Expenses were $2.3 million (Q4 2025), $2.3 million (Q3 2025), and $2.4 million (Q2 2025) per Business Quant data.